CLSD Quote, Trading Chart, Clearside Biomedical Inc.
home / stock / clsd / clsd quote
$4.84 Last:
-10.04% Change Percent:
$5.2 Open:
$4.84 Previous Close:
$5.4 High:
$4.81 Low:
2,233,349 Volume:
06/24/2021 04:41:41 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CLSD Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-24 | 5.2 | 4.84 | 5.4 | 4.81 | 2,233,349 |
| 2021-06-23 | 4.515 | 5.38 | 5.65 | 4.46 | 5,956,463 |
| 2021-06-22 | 4.41 | 4.54 | 4.64 | 4.39 | 907,733 |
| 2021-06-21 | 4.6504 | 4.51 | 4.79 | 4.35 | 1,437,029 |
| 2021-06-18 | 4.33 | 4.84 | 4.96 | 4.15 | 5,070,857 |
| 2021-06-17 | 4.9918 | 4.64 | 6 | 4.41 | 43,026,933 |
| 2021-06-16 | 3.78 | 4.08 | 4.15 | 3.58 | 3,913,315 |
| 2021-06-15 | 3.999 | 4.16 | 4.7996 | 3.6167 | 90,681,101 |
| 2021-06-14 | 3.04 | 3.02 | 3.12 | 3.01 | 59,412 |
| 2021-06-11 | 3.11 | 3.01 | 3.168 | 3.01 | 71,663 |
| 2021-06-10 | 3.07 | 3.11 | 3.1306 | 3 | 114,018 |
| 2021-06-09 | 3.18 | 3.08 | 3.25 | 3.03 | 188,717 |
| 2021-06-08 | 3.2 | 3.13 | 3.27 | 3.0101 | 296,161 |
| 2021-06-07 | 2.94 | 3.16 | 3.1999 | 2.895 | 327,980 |
| 2021-06-04 | 2.87 | 2.89 | 2.89 | 2.75 | 120,284 |
| 2021-06-03 | 2.78 | 2.76 | 2.92 | 2.71 | 82,637 |
| 2021-06-02 | 2.79 | 2.82 | 2.95 | 2.72 | 377,169 |
| 2021-06-01 | 2.58 | 2.67 | 2.694 | 2.5 | 185,618 |
| 2021-05-31 | 2.56 | 2.565 | 2.6242 | 2.46 | 167,072 |
| 2021-05-28 | 2.56 | 2.565 | 2.6242 | 2.46 | 166,786 |
Clearside Biomedical Inc. Company Name:
CLSD Stock Symbol:
NASDAQ Market:
Clearside Biomedical Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
- Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders - - CLS-AX will also be featured at the upcoming virtual Angiogenesis, Exudation, and Degeneration 2021 conference on February 13, 2021 - ALPHARETTA, ...
-
ALPHARETTA, Ga., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the first p...
-
ALPHARETTA, Ga., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that it has ente...